Co-Authors
This is a "connection" page, showing publications co-authored by Marco Metra and Carlo Lombardi.
Connection Strength
5.671
-
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy. J Card Fail. 2018 09; 24(9):550-552.
Score: 0.781
-
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. Clin Med Insights Cardiol. 2014; 8:39-44.
Score: 0.583
-
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace. 2021 10 09; 23(10):1603-1611.
Score: 0.243
-
Thrombotic risk in patients with COVID-19. Rev Cardiovasc Med. 2021 06 30; 22(2):277-286.
Score: 0.238
-
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study. Int J Infect Dis. 2021 Jul; 108:270-273.
Score: 0.237
-
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr Heart Fail Rep. 2021 06; 18(3):99-106.
Score: 0.235
-
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. Eur J Heart Fail. 2020 12; 22(12):2238-2247.
Score: 0.229
-
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
Score: 0.228
-
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020 Nov 01; 5(11):1274-1280.
Score: 0.228
-
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2020 Nov; 21(11):874-881.
Score: 0.228
-
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 07 01; 5(7):819-824.
Score: 0.223
-
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020 Jun; 22(6):957-966.
Score: 0.222
-
June 2020 at a glance: focus on COVID-19, quality of life and comorbidities. Eur J Heart Fail. 2020 06; 22(6):917-918.
Score: 0.221
-
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 05 14; 41(19):1821-1829.
Score: 0.220
-
Updates in heart failure: what last year brought to us. ESC Heart Fail. 2018 12; 5(6):989-1007.
Score: 0.199
-
Sacubitril/valsartan: from a large clinical trial to clinical practice. J Cardiovasc Med (Hagerstown). 2018 Sep; 19(9):473-479.
Score: 0.196
-
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients. Cardiovasc Ther. 2018 Jun; 36(3):e12323.
Score: 0.189
-
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography. Monaldi Arch Chest Dis. 2017 07 18; 87(2):863.
Score: 0.181
-
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol Heart Vessel. 2014 Jun; 3:78-81.
Score: 0.145
-
The prognostic value of serial troponin measurements in patients admitted for COVID-19. ESC Heart Fail. 2021 10; 8(5):3504-3511.
Score: 0.060
-
Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The "macro-hub" experience. Int J Cardiol Heart Vasc. 2020 Dec; 31:100662.
Score: 0.057
-
Cardiogenic Shock due to COVID-19-Related Myocarditis in a 19-Year-Old Autistic Patient. J Med Cases. 2020 Jul; 11(7):207-210.
Score: 0.056
-
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail. 2019 02; 21(2):208-217.
Score: 0.050
-
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail. 2019 02; 21(2):196-204.
Score: 0.050
-
Iron deficiency in heart failure. J Cardiovasc Med (Hagerstown). 2018 Dec; 19(12):706-716.
Score: 0.050
-
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation. Cardiovasc Pathol. 2019 Jan - Feb; 38:21-24.
Score: 0.050
-
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects. Eur J Pharmacol. 2018 Nov 05; 838:85-90.
Score: 0.049
-
Dose-dependent efficacy of ß-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol. 2018 Dec 15; 273:141-146.
Score: 0.049
-
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
Score: 0.046
-
Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
Score: 0.044
-
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. Int J Cardiol. 2017 May 01; 234:53-57.
Score: 0.044
-
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail. 2016 Mar; 22(3):182-9.
Score: 0.041